KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Capital Employed: 2011-2024

Historic Return on Capital Employed for TherapeuticsMD (TXMD) over the last 14 years, with Dec 2024 value amounting to -0.13%.

  • TherapeuticsMD's Return on Capital Employed rose 15.00% to -0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.05%, marking a year-over-year increase of 15.00%. This contributed to the annual value of -0.13% for FY2024, which is 1.00% up from last year.
  • TherapeuticsMD's Return on Capital Employed amounted to -0.13% in FY2024, which was up 6.61% from -0.14% recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Return on Capital Employed ranged from a high of 1.03% in FY2021 and a low of -0.95% during FY2020.
  • In the last 3 years, TherapeuticsMD's Return on Capital Employed had a median value of -0.13% in 2024 and averaged -0.09%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first surged by 197bps in 2021, then tumbled by 101bps in 2022.
  • Over the past 5 years, TherapeuticsMD's Return on Capital Employed (Yearly) stood at -0.95% in 2020, then surged by 197bps to 1.03% in 2021, then tumbled by 101bps to 0.01% in 2022, then decreased by 16bps to -0.14% in 2023, then climbed by 1bps to -0.13% in 2024.